Skip to main content
Top
Published in: Tumor Biology 5/2013

01-10-2013 | Editorial

Long noncoding RNA AC096655.1-002 has been officially named as gastric cancer-associated transcript 1, GACAT1

Authors: Bingxiu Xiao, Junming Guo

Published in: Tumor Biology | Issue 5/2013

Login to get access

Excerpt

Shortly after the article entitled “Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance” published in Tumor Biology [1], the long noncoding RNA AC096655.1-002 that studied in this paper has been officially named by HUGO Gene Nomenclature Committee (HGNC). Readers can find the detail information from Human Gene Nomenclature Database (www.​genenames.​org/​hgnc-searches). Its HGNC ID is HGNC: 48336. Its synonym is AC096655.1-002, LINC00876, “long intergenic non-protein coding RNA 876.” Its gene is located at 2q12.3. …
Literature
1.
go back to reference Sun W, Wu Y, Yu X, Liu Y, Song H, Xia T, et al. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Tumor Biol. 2013. doi:10.1007/s13277-013-0821-0. Sun W, Wu Y, Yu X, Liu Y, Song H, Xia T, et al. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Tumor Biol. 2013. doi:10.​1007/​s13277-013-0821-0.
Metadata
Title
Long noncoding RNA AC096655.1-002 has been officially named as gastric cancer-associated transcript 1, GACAT1
Authors
Bingxiu Xiao
Junming Guo
Publication date
01-10-2013
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2013
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0916-7

Other articles of this Issue 5/2013

Tumor Biology 5/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine